Researchers are in a hurry to develop an effective vaccine against the new coronavirus. As the race intensifies, wealthy countries are placing orders for the treatment before it is even approved. They will be among the first to get what is likely to be a limited supply of the vaccine. This leaves questions about whether developing nations will get any vaccines in time to save lives. The COVID-19 pandemic has affected 188 countries and territories. By June 18, the disease had infected nearly 8.4 million people and caused about 450,000 deaths. The World Health Organization has prepared a list of nearly 140 efforts to develop effective treatments and vaccines for the virus. The list includes 11 vaccine candidates undergoing human trials in China, Britain, and the United States. The tests involve products from drug makers like AstraZeneca, Pfizer, Inovio, and Moderna.